Manifestations of Herpes Virus Infections in the Nervous System

Neurologic Clinics

Volumn 36, Issue 4, 2018, Pages 725-738

  Steiner, Israel ^a,b   Benninger, Felix ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Encephalitis; Herpes simplex virus; Meningoencephalitis; Postinfection; Reactivation infection; Varicella zoster virus

Indexed keywords

ACICLOVIR; AMITRIPTYLINE; CAPSAICIN; CIDOFOVIR; DEXAMETHASONE; FAMCICLOVIR; FOSCARNET; GABAPENTIN; LIDOCAINE; MANNITOL; MORPHINE; OXYCODONE; PENCICLOVIR; PREGABALIN; TRAMADOL; VALACICLOVIR;

ALZHEIMER DISEASE; ASEPTIC MENINGITIS; BELL PALSY; CENTRAL NERVOUS SYSTEM INFECTION; CEREBELLAR ATAXIA; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; ENCEPHALITIS; GIANT CELL ARTERITIS; GUILLAIN BARRE SYNDROME; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; HERPES ZOSTER; HUMAN; MENINGOENCEPHALITIS; MOTOR DYSFUNCTION; MYELITIS; NEONATAL ENCEPHALITIS; OPTIC NEURITIS; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; REVIEW; REYE SYNDROME; VARICELLA ZOSTER VIRUS; VASCULITIS; VIRUS LATENCY; VIRUS MORPHOLOGY; VIRUS REACTIVATION; HERPES ZOSTER ENCEPHALITIS;

ENCEPHALITIS, HERPES SIMPLEX; ENCEPHALITIS, VARICELLA ZOSTER; HUMANS;

EID: 85055285274     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2018.06.005     Document Type: Review

References (40)

1. Cumston, C.G., The history of herpes from the earliest times to the nineteenth century. Ann Med Hist 8 (1926), 284–291.
2. Steiner, I., Kennedy, P.G., Herpes simplex virus latent infection in the nervous system. J Neurovirol 1:1 (1995), 19–29.
3. Goodpastur, E.W., Herpetic Infection, with especial reference to involvement of the nervous system. Medicine, 8(2), 1929, 223.
4. Hope-Simpson, R.E., The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58:1 (1965), 9–20.
5. Steiner, I., Spivack, J.G., Deshmane, S.L., et al. A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia. J Virol 64:4 (1990), 1630–1638.
6. Steiner, I., Kennedy, P.G., Herpes simplex virus latency in the nervous system–a new model. Neuropathol Appl Neurobiol 17:6 (1991), 433–440.
7. Rock, D.L., Fraser, N.W., Detection of HSV-1 genome in central nervous system of latently infected mice. Nature 302:5908 (1983), 523–525.
8. Croen, K.D., Ostrove, J.M., Dragovic, L., et al. Characterization of herpes simplex virus type 2 latency-associated transcription in human sacral ganglia and in cell culture. J Infect Dis 163:1 (1991), 23–28.
9. Krause, P.R., Stanberry, L.R., Bourne, N., et al. Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs. J Exp Med 181:1 (1995), 297–306.
10. Clarke, P., Beer, T., Cohrs, R., et al. Configuration of latent varicella-zoster virus DNA. J Virol 69:12 (1995), 8151–8154.
11. Kennedy, P.G., Grinfeld, E., Bell, J.E., Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J Virol 74:24 (2000), 11893–11898.
12. Kennedy, P.G.E., Steiner, I., A molecular and cellular model to explain the differences in reactivation from latency by herpes simplex and varicella-zoster viruses. Neuropathol Appl Neurobiol 20:4 (1994), 368–374.
13. Smith, J.S., Robinson, N.J., Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 186:Suppl 1 (2002), S3–S28.
14. Heininger, U., Seward, J.F., Varicella. Lancet 368:9544 (2006), 1365–1376.
15. Kennedy, P.G.E., Chaudhuri, A., Herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 73:3 (2002), 237–238.
16. Davis, L.E., Johnson, R.T., An explanation for the localization of herpes simplex encephalitis?. Ann Neurol 5:1 (1979), 2–5.
17. Stroop, W.G., Schaefer, D.C., Production of encephalitis restricted to the temporal lobes by experimental reactivation of herpes simplex virus. J Infect Dis 153:4 (1986), 721–731.
18. Whitley, R., Lakeman, A.D., Nahmias, A., et al. DNA restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med 307:17 (1982), 1060–1062.
19. Mador, N., Goldenberg, D., Cohen, O., et al. Herpes simplex virus type 1 latency-associated transcripts suppress viral replication and reduce immediate-early gene mRNA levels in a neuronal cell line. J Virol 72:6 (1998), 5067–5075.
20. Casrouge, A., Zhang, S.-Y., Eidenschenk, C., et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:5797 (2006), 308–312.
21. Steiner, I., Schmutzhard, E., Sellner, J., et al. EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system. Eur J Neurol 19:10 (2012), 1278–1291.
22. McGrath, N., Anderson, N.E., Croxson, M.C., et al. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry 63:3 (1997), 321–326.
23. Hasbun, R., Abrahams, J., Jekel, J., et al. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 345:24 (2001), 1727–1733.
24. Whitley, R., Arvin, A., Prober, C., et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 324:7 (1991), 444–449.
25. Cinque, P., Cleator, G.M., Weber, T., et al. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU concerted action on virus meningitis and encephalitis. J Neurol Neurosurg Psychiatry 61:4 (1996), 339–345.
26. Ito, Y., Kimura, H., Yabuta, Y., et al. Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. Clin Infect Dis 30:1 (2000), 185–187.
27. Solomon, T., Michael, B.D., Smith, P.E., et al. Management of suspected viral encephalitis in adults – Association of British Neurologists and British Infection Association national guidelines. J Infect 64:4 (2012), 347–373.
28. Whitley, R., Arvin, A., Prober, C., et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The national Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 324:7 (1991), 450–454.
29. Patel, R., Kennedy, O.J., Clarke, E., et al. 2017 European guidelines for the management of genital herpes. Int J STD AIDS 28:14 (2017), 1366–1379.
30. Berger, J.R., Benign aseptic (Mollaret's) meningitis after genital herpes. Lancet 337:8753 (1991), 1360–1361.
31. Ragozzino, M.W., Melton, L.J., Kurland, L.T., et al. Risk of cancer after herpes zoster: a population-based study. N Engl J Med 307:7 (1982), 393–397.
32. Kennedy, P.G.E., Neurological complications of varicella-zoster virus. Kennedy, P.G.E., Johnson, R.D., (eds.) Infections of the nervous system, 2000, Butterworth-Heinemann, Oxford (England), 177–208.
33. Steiner, I., Steiner-Birmanns, B., Levin, N., et al. Spinal cord involvement in uncomplicated herpes zoster. Clin Diagn Lab Immunol 8:4 (2001), 850–851.
34. Kost, R.G., Straus, S.E., Postherpetic neuralgia — pathogenesis, treatment, and prevention. N Engl J Med 335:1 (1996), 32–42.
35. Vafai, A., Wellish, M., Gilden, D.H., Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proc Natl Acad Sci U S A 85:8 (1988), 2767–2770.
36. Itzhaki, R.F., Herpes simplex virus type 1 and Alzheimer's disease: possible mechanisms and signposts. FASEB J 31:8 (2017), 3216–3226.
37. Itzhaki, R.F., Lin, W.-R., Shang, D., et al. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349:9047 (1997), 241–244.
38. Steiner, I., Mattan, Y., Bell's palsy and herpes viruses: to (acyclo)vir or not to (acyclo)vir?. J Neurol Sci 170:1 (1999), 19–23.
39. Gilden, D., White, T., Khmeleva, N., et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology 84:19 (2015), 1948–1955.
40. Lotan, I., Steiner, I., Giant cell arteritis following varicella zoster vaccination. J Neurol Sci 375 (2017), 158–159.